Protecting pediatric oncology patients from influenza.

TitleProtecting pediatric oncology patients from influenza.
Publication TypeJournal Article
Year of Publication2013
AuthorsKersun LS, Reilly AF, Coffin SE, Sullivan KE
JournalOncologist
Volume18
Issue2
Pagination204-11
Date Published2013 Feb
ISSN1549-490X
KeywordsChild, Humans, Influenza Vaccines, Influenza, Human, Neoplasms, Risk Factors, Vaccination
Abstract

Influenza is a common respiratory pathogen. Its severity can be unpredictable, but people with chronic illness are at increased risk of severe infection, complications, and death from influenza. This review examines evidence to support various strategies to protect pediatric oncology patients from influenza-related morbidity. Influenza vaccination should be considered standard. Additional evidence-supported measures include antiviral treatment, antiviral prophylaxis, cohorting of patients, and hospital infection control measures. Data from other high-risk populations support the vaccination of family members, double-dose or high-dose vaccination, and the use of barrier methods. These measures have the potential to optimize patient outcomes because there will be fewer treatment interruptions for acute illness. These strategies can also protect patients from prolonged hospitalizations and morbidity related to influenza.

DOI10.1634/theoncologist.2012-0401
Alternate JournalOncologist
PubMed ID23370325
PubMed Central IDPMC3579605
Grant ListN01-AI-50024 / AI / NIAID NIH HHS / United States